By integrating genomic and clinical data from a large, multi-ethnic cohort, our goal is to identify ancestry- and age-specific PI3K pathway alterations associated with treatment exposure, thereby informing precision oncology approaches tailored to high-risk and underserved CRC populations. Here, PIK3CA is linked to colorectal carcinoma.